# Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial

Study · id `cardio:ct-nct02285920` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02285920](<https://clinicaltrials.gov/study/NCT02285920>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02285920

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 129 participants.

## Technical summary

Registry record NCT02285920. Randomized; quadruple masking; primary purpose treatment. Start 2014-11 (registry gives no type); primary completion 2017-06 (actual). Results posted on 2019-07-23.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 129 participants (enrolled count; ClinicalTrials.gov record NCT02285920, source copy `cardio:ctgov-nct02285920-2019-07-23`, retrieved 2026-10-26)
- Start date: 2014-11 (registry gives no type) (ClinicalTrials.gov record NCT02285920, source copy `cardio:ctgov-nct02285920-2019-07-23`, retrieved 2026-10-26)
- Primary completion: 2017-06 (actual) (ClinicalTrials.gov record NCT02285920, source copy `cardio:ctgov-nct02285920-2019-07-23`, retrieved 2026-10-26)
- Completion: 2017-07-30 (actual) (ClinicalTrials.gov record NCT02285920, source copy `cardio:ctgov-nct02285920-2019-07-23`, retrieved 2026-10-26)
- Results first posted: 2019-07-23 (ClinicalTrials.gov record NCT02285920, source copy `cardio:ctgov-nct02285920-2019-07-23`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02285920, source copy `cardio:ctgov-nct02285920-2019-07-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02285920-2019-07-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial
- Acronym: SPin-D
- Condition: End-Stage Renal Disease
- Intervention (Drug): Spironolactone
- Lead sponsor: University of Pennsylvania
- Lead sponsor class: OTHER
- Collaborator: Brigham and Women's Hospital
- Collaborator class: OTHER
- Collaborator: George Washington University
- Collaborator class: OTHER
- Collaborator: Vanderbilt University
- Collaborator class: OTHER
- Collaborator: University of Washington
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: University of Pennsylvania (`cardio:org-university-of-pennsylvania`)
- Registry lists this organization as a collaborator: Brigham and Women's Hospital (`cardio:org-brigham-and-women-s-hospital`)
- Registry lists this organization as a collaborator: George Washington University (`cardio:org-george-washington-university`)
- Registry lists this organization as a collaborator: Vanderbilt University (`cardio:org-vanderbilt-university`)
- Registry lists this organization as a collaborator: University of Washington (`cardio:org-university-of-washington`)

## Provenance

Content hash: 355cf37b5bf5b4fd658e3b44ed41c895f36f395f9b4fcb3f25b52061087de2cb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
